An investigation of mineral absorption: a randomized, double-blind, placebo-controlled, crossover trial.

Not Applicable

• Conditions: Healthy Japanese subjects

• Registration Number: JPRN-UMIN000034976
• Lead Sponsor: ORTHOMEDICO Inc.

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-11-22
• Study Completion: 2019-06-04
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 24

Inclusion Criteria

Not provided

Exclusion Criteria

1. Subjects who are undergoing medical treatment or have a medical history of malignant tumor, heart failure or myocardial infarction 2. Subjects who have a pacemaker or an implantable cardioverter defibrillator (ICD) 3. Currently undergoing treatment for any of the following chronic diseases: cardiac arrhythmia, liver disease, kidney disease, kidney stone, cerebrovascular disorder, rheumatism, diabetes mellitus, hypercalcemia, dyslipidemia, hypertension, or any other chronic diseases 4. Subjects who regularly take calcium-rich foods such as calcium-fortified milk 5. Subjects who use or take "Foods for Specified Health Uses", "Foods with Function Claims", or other functional food/beverage in daily 6. Subjects who have physical labor in perspiration 7. Subjects who work late-night shift and the lifestyles are irregular 8. Subjects who cannot control their room temperature including not having any air conditioners and heaters 9. Subjects who have a tendency toward constipation or diarrhea 10. Subjects who have excessive fitness habit 11. Subjects who have a drinking habit 12. Subjects who are currently taking medications (including herbal medicines) and dietary supplements 13. Subjects who are an allergic reaction to medications and/or the test food related products 14. Subjects who are pregnant, breast-feeding, or planning to become pregnant 15. Subjects who have been enrolled in other clinical trials within the last three months before the agreement to participate in this trial or plan to participate another trial during this trial 16. Subjects who are judged as ineligible to participate in the study by the physician

Study & Design

• Study Type: Interventional
• Study Design: Not specified